New 3-Week radiation plan aims to cut side effects for sarcoma patients
NCT ID NCT07169344
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a personalized 3-week course of proton radiation before surgery for soft tissue sarcoma can reduce long-term side effects compared to standard X-ray radiation. About 110 adults in Norway will receive either proton or X-ray therapy, chosen individually for each patient. The main goal is to see if this approach lowers surgical complications within 120 days after surgery, while also tracking cancer control and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEIOMYOSARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Haukeland University Hospital
NOT_YET_RECRUITINGBergen, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oslo University Hospital
RECRUITINGOslo, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St. Olavs University Hospital
NOT_YET_RECRUITINGTrondheim, Norway
Contact Phone: •••-•••-••••
-
University Hospital of North Norway
NOT_YET_RECRUITINGTromsø, Norway
Contact Phone: •••-•••-••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental combo aims to tackle Treatment-Resistant cancers
- Blood test may spot hidden sarcoma signals
- New pill may keep soft tissue sarcoma in check after chemo
- New drug takes aim at Hard-to-Treat sarcoma
- Dietary change explored as cancer support strategy
- New combo therapy aims to shrink sarcomas